Coats Disease Clinical Trial
— COATS+Official title:
Coats Plus Syndrome and LCC Syndrome: Series of 10 Pediatric Cases. Review of Literature and Natural History
Verified date | March 2020 |
Source | University Hospital, Limoges |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Coats plus syndrome is a very rare and serious disease, caused by premature telomere
shortening. It is a pediatric, multi-systemic disease, the main features of which are retinal
vasculopathy and neurological disorders, associated with brain calcification and
leukodystrophy. Its precise genetic etiology was discovered in 2012: autosomal recessive
mutation of the CTC1 gene.
Publications about this syndrome are very few, and consist only of case reports, or small
series of cases. This is explained by the rarity of occurrence of this syndrome. Since 1988,
57 cases of Coats plus syndrome have been published, with case series of up to 13 patients.
Only 28 cases were detailed concerning the precise clinical presentation in the literature.
The general characteristics of this syndrome are known and, in addition to the
ophthalmological and neurological damage, the various publications have been able to report a
digestive attack (hemorrhages), hematological damage (central cytopenias), or increased bone
fragility. No treatment is currently available to cure patients.
The natural history of this disease is poorly known. However, the most accurate knowledge
possible of this disease, and its natural history, is essential. It would allow an easier
identification of this rare syndrome, the establishment of a management (monitoring and
therapeutic) adapted, and a more accurate genetic counseling in case of need of a prenatal
diagnosis.
The description of a new series of unpublished cases, as well as a comprehensive review of
the literature on Coats plus syndrome, will provide a more comprehensive and informed view of
this disease.
Moreover, LCC syndrome (leukoencephalopathy with calcifications and cysts) is an autosomal
recessive disorder linked to a mutation in the SNORD118 gene, which has the particularity of
presenting the same neurological (neuro-radiological and clinical) characteristics, but
without associating the others. ophthalmological and systemic disorders. It constitutes the
differential radiological diagnosis of Coats plus syndrome. In this, the collection of
medical data of French pediatric cases presenting this syndrome will allow a more detailed
analysis of the differences and similarities between these two syndromes.
Status | Completed |
Enrollment | 10 |
Est. completion date | December 31, 2019 |
Est. primary completion date | December 31, 2019 |
Accepts healthy volunteers | |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Patient with Coats plus genetic and / or clinical Syndrome, pediatric onset - Patients with genetic and / or clinical LCC syndrome, pediatric onset Exclusion Criteria: - Refusal of the patient or his family (oral opposition) |
Country | Name | City | State |
---|---|---|---|
France | Hopital Kremlin Bicêtre | Le Kremlin-Bicêtre | |
France | CHU de Limoges | Limoges | |
France | Hospices civils de Lyon | Lyon | |
France | Fondation Adolphe de ROTHSCHILD | Paris | |
France | Hopital Robert Debré | Paris | |
France | CHU de Rennes | Rennes |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Limoges |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome | percentage of patients with neurological complication : seizures Exploratory description for each patient | through study completion, an average of 1 year | |
Primary | Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome | percentage of patients with neurological complication : focal clinical abnormality Exploratory description for each patient | through study completion, an average of 1 year | |
Primary | Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome | percentage of patients with neurological complication : cognitive trouble. Exploratory description for each patient | through study completion, an average of 1 year | |
Primary | Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome | percentage of patients with abnormal brain imaging : exploratory description for each patient | through study completion, an average of 1 year | |
Primary | Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome | percentage of patients with digestive complication : bleeding Exploratory description for each patient | through study completion, an average of 1 year | |
Primary | Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome | percentage of patients with digestive complication :hepatic disease Exploratory description for each patient | through study completion, an average of 1 year | |
Primary | Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome | percentage of patients with bone complication : osteoporosis Exploratory description for each patient | through study completion, an average of 1 year | |
Primary | Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome | Percentage of patients with ophthalmologic complication : Coats disease Exploratory description for each patient | through study completion, an average of 1 year | |
Primary | Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome | Percentage of patients with hair or nails abnormality Exploratory description for each patient | through study completion, an average of 1 year | |
Primary | Precise exploration of clinical and paraclinical description of paediatric Coats plus syndrome and LCC syndrome about the French pediatric patients with paediatric Coats plus syndrome, or their differential diagnosis of LCC syndrome | Percentage of patients with intra uterine growth retardation or neonatal trouble : exploratory description for each patient Any disease or complication in the medical history | through study completion, an average of 1 year | |
Secondary | Precise exploration of clinical and paraclinical description of paediatric Coats + and LCC syndrome, already described in the literature about clinical cases with paediatric Coats+ syndrome, or their differential diagnosis of LCC syndrome | percentage of patients with neurological complication : seizures Exploratory description for each patient | through study completion, an average of 1 year | |
Secondary | Precise exploration of clinical and paraclinical description of paediatric Coats + and LCC syndrome, already described in the literature about clinical cases with paediatric Coats+ syndrome, or their differential diagnosis of LCC syndrome | percentage of patients with neurological complication : focal clinical abnormality Exploratory description for each patient | through study completion, an average of 1 year | |
Secondary | Precise exploration of clinical and paraclinical description of paediatric Coats + and LCC syndrome, already described in the literature about clinical cases with paediatric Coats+ syndrome, or their differential diagnosis of LCC syndrome | percentage of patients with neurological complication : cognitive trouble. Exploratory description for each patient | through study completion, an average of 1 year | |
Secondary | Precise exploration of clinical and paraclinical description of paediatric Coats + and LCC syndrome, already described in the literature about clinical cases with paediatric Coats+ syndrome, or their differential diagnosis of LCC syndrome | percentage of patients with abnormal brain imaging : exploratory description for each patient | through study completion, an average of 1 year | |
Secondary | Precise exploration of clinical and paraclinical description of paediatric Coats + and LCC syndrome, already described in the literature about clinical cases with paediatric Coats+ syndrome, or their differential diagnosis of LCC syndrome | percentage of patients with digestive complication : bleeding Exploratory description for each patient | through study completion, an average of 1 year | |
Secondary | Precise exploration of clinical and paraclinical description of paediatric Coats + and LCC syndrome, already described in the literature about clinical cases with paediatric Coats+ syndrome, or their differential diagnosis of LCC syndrome | percentage of patients with digestive complication :hepatic disease Exploratory description for each patient | through study completion, an average of 1 year | |
Secondary | Precise exploration of clinical and paraclinical description of paediatric Coats + and LCC syndrome, already described in the literature about clinical cases with paediatric Coats+ syndrome, or their differential diagnosis of LCC syndrome | percentage of patients with bone complication : osteoporosis Exploratory description for each patient | through study completion, an average of 1 year | |
Secondary | Precise exploration of clinical and paraclinical description of paediatric Coats + and LCC syndrome, already described in the literature about clinical cases with paediatric Coats+ syndrome, or their differential diagnosis of LCC syndrome | Percentage of patients with ophthalmologic complication : Coats disease Exploratory description for each patient | through study completion, an average of 1 year | |
Secondary | Precise exploration of clinical and paraclinical description of paediatric Coats + and LCC syndrome, already described in the literature about clinical cases with paediatric Coats+ syndrome, or their differential diagnosis of LCC syndrome | Percentage of patients with hair or nails abnormality Exploratory description for each patient | through study completion, an average of 1 year | |
Secondary | Precise exploration of clinical and paraclinical description of paediatric Coats + and LCC syndrome, already described in the literature about clinical cases with paediatric Coats+ syndrome, or their differential diagnosis of LCC syndrome | Percentage of patients with intra uterine growth retardation or neonatal trouble : exploratory description for each patient Any disease or complication in the medical history | through study completion, an average of 1 year | |
Secondary | Estimation of the natural history of the disease for morbidity and mortality from the data of the new case series and case data from the literature : | Average age at first symptoms Distribution of type of first symptoms Average age at diagnostic Average age at death if applicable Average age at beginning of each organ complications (ophthalmologic, neurologic, digestive, bony, or any other) Average delay of neurological deterioration Average age | through study completion, an average of 1 year | |
Secondary | Define a neuro-radiological pattern associated with Coats plus syndrome and LCC syndrome from the imaging data in the new French series | Blinded interpretation of MRI and CT scan Particular attention will be done about calcifications, white matter abnormalities and cysts : presence, brain localization Exploratory description of each brain abnormality found % of patients presenting each abnormality found and its precise description (brain localization in particular) |
through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT03940690 -
Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease
|
Phase 3 | |
Completed |
NCT04310631 -
Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab
|